MDB Capital Holdings LLC has unveiled a new PatentVest Pulse report titled "The Next Era of Surgical Robotics," offering an in-depth analysis of the $188 billion surgical robotics market. The report highlights a significant shift away from reliance on a single system, such as the da Vinci system, towards a competitive race for platform defensibility. Key players like Medtronic, Johnson & Johnson, Zimmer Biomet, Stryker, and Smith+Nephew remain influential, while emerging challengers such as Vicarious Surgical and Microbot Medical are gaining momentum in niche areas. Venture-backed companies, including CMR Surgical and THINK Surgical, are aligning strategically for scale, positioning themselves as potential acquisition targets. Despite the vast number of global surgeries annually, robotic involvement remains low due to cost and complexity. The report emphasizes IP positioning, regulatory progress, and scalability as critical factors for future market leaders, noting Intuitive Surgical's dominance is being challenged by new entrants. The comprehensive analysis provides strategic insights for investors and industry leaders, identifying potential future market disruptors.